Peterson receives $1.4M grant for innovative approach to attacking metastatic TNBC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jeffrey Peterson, associate professor of cancer biology with the Breast Cancer Translational Research Disease Group at Fox Chase Cancer Center, received a $1.4 million grant from the U.S. Department of Defense to evaluate and exploit the mechanisms of inducing programmed cell death using polyunsaturated fatty acids in triple-negative breast cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

VOICES of Black Women, the largest population study of Black women in the United States, will be the first of American Cancer Society’s large-scale population studies to be initiated using an AI-driven data management platform—promising to bring observational cancer research out of the age of Excel data files and email sharing.

Login